A Randomised, Double-blind, Double-dummy, Single Dose, Four Way Cross-over Study to Compare the Pharmacokinetics and Pharmacodynamics of GSK961081 and Fluticasone Propionate When Administered Alone, Concurrently and as a Combination Blend in Healthy Subjects
Latest Information Update: 07 Jan 2024
At a glance
- Drugs Batefenterol (Primary) ; Fluticasone propionate; Fluticasone propionate/GSK 961081
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 13 Oct 2011 New trial record